BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 25325841)

  • 1. New outcomes with auditory brainstem implants in NF2 patients.
    Behr R; Colletti V; Matthies C; Morita A; Nakatomi H; Dominique L; Darrouzet V; Brill S; Shehata-Dieler W; Lorens A; Skarzynski H
    Otol Neurotol; 2014 Dec; 35(10):1844-51. PubMed ID: 25325841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Auditory Brainstem Implantation in Chinese Patients With Neurofibromatosis Type II: The Hong Kong Experience.
    Thong JF; Sung JK; Wong TK; Tong MC
    Otol Neurotol; 2016 Aug; 37(7):956-62. PubMed ID: 27273391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Auditory brainstem implants for neurofibromatosis type 2.
    Colletti L; Shannon R; Colletti V
    Curr Opin Otolaryngol Head Neck Surg; 2012 Oct; 20(5):353-7. PubMed ID: 22886036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Auditory brainstem implants in NF2 patients: results and review of the literature.
    Sanna M; Di Lella F; Guida M; Merkus P
    Otol Neurotol; 2012 Feb; 33(2):154-64. PubMed ID: 22246383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing Speech Recognition Outcomes Between Cochlear Implants and Auditory Brainstem Implants in Patients With NF2-Related Schwannomatosis.
    Dornhoffer JR; Plitt AR; Lohse CM; Driscoll CLW; Neff BA; Saoji AA; Van Gompel JJ; Link MJ; Carlson ML
    Otol Neurotol; 2024 Jan; 45(1):29-35. PubMed ID: 37875011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Auditory brainstem implants in neurofibromatosis Type 2: is open speech perception feasible?
    Matthies C; Brill S; Varallyay C; Solymosi L; Gelbrich G; Roosen K; Ernestus RI; Helms J; Hagen R; Mlynski R; Shehata-Dieler W; Müller J
    J Neurosurg; 2014 Feb; 120(2):546-58. PubMed ID: 24329026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Auditory brainstem implantation improves speech recognition in neurofibromatosis type II patients.
    Matthies C; Brill S; Kaga K; Morita A; Kumakawa K; Skarzynski H; Claassen A; Hui Y; Chiong C; Müller J; Behr R
    ORL J Otorhinolaryngol Relat Spec; 2013; 75(5):282-95. PubMed ID: 24042846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Auditory Brainstem Implantation in Neurofibromatosis Type 2: Experience From the Manchester Programme.
    Ramsden RT; Freeman SR; Lloyd SK; King AT; Shi X; Ward CL; Huson SM; Mawman DJ; O'Driscoll MP; Evans DG; Rutherford SA;
    Otol Neurotol; 2016 Oct; 37(9):1267-74. PubMed ID: 27525707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Auditory brainstem implant in neurofibromatosis type 2 and non-neurofibromatosis type 2 patients.
    Grayeli AB; Kalamarides M; Bouccara D; Ambert-Dahan E; Sterkers O
    Otol Neurotol; 2008 Dec; 29(8):1140-6. PubMed ID: 18849886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hearing Rehabilitation in Patients With Neurofibromatosis Type 2: The Quebec's Experience With Auditory Implants.
    Khneisser E; Bussieres R; Côté M; Philippon D; Fradet G; Côté M; Lessard N; Champagne PO; Trudel M
    Otol Neurotol; 2023 Sep; 44(8):e621-e627. PubMed ID: 37550875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Auditory brainstem implant (ABI): new frontiers in adults and children.
    Colletti V; Carner M; Miorelli V; Guida M; Colletti L; Fiorino F
    Otolaryngol Head Neck Surg; 2005 Jul; 133(1):126-38. PubMed ID: 16025066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrically Evoked Auditory Event-Related Responses in Patients with Auditory Brainstem Implants: Morphological Characteristics, Test-Retest Reliability, Effects of Stimulation Level, and Association with Auditory Detection.
    He S; McFayden TC; Teagle HF; Ewend M; Henderson L; Buchman CA
    Ear Hear; 2016; 37(6):634-649. PubMed ID: 27579988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multichannel auditory brainstem implant: update on performance in 61 patients.
    Otto SR; Brackmann DE; Hitselberger WE; Shannon RV; Kuchta J
    J Neurosurg; 2002 Jun; 96(6):1063-71. PubMed ID: 12066908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Statistical Analyses to Assess Hearing Outcomes After ABI Implantation in NF2 Patients: Systematic Review and Individualized Patient Data Analysis.
    Taslimi S; Zuccato JA; Mansouri A; Hachem LD; Badhiwala J; Kuchta J; Chen J; Pirouzmand F
    World Neurosurg; 2019 Aug; 128():e669-e682. PubMed ID: 31059859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Auditory Brainstem Implantation for Adults With Neurofibromatosis 2 or Severe Inner Ear Abnormalities: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2020; 20(4):1-85. PubMed ID: 32190165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Auditory brainstem implantation in patients with neurofibromatosis type 2.
    Kanowitz SJ; Shapiro WH; Golfinos JG; Cohen NL; Roland JT
    Laryngoscope; 2004 Dec; 114(12):2135-46. PubMed ID: 15564834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tinnitus Suppression After Auditory Brainstem Implantation in Patients With Neurofibromatosis Type-2.
    Roberts DS; Otto S; Chen B; Peng KA; Schwartz MS; Brackmann DE; House JW
    Otol Neurotol; 2017 Jan; 38(1):118-122. PubMed ID: 27755361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Auditory outcomes in tumor vs. nontumor patients fitted with auditory brainstem implants.
    Colletti V
    Adv Otorhinolaryngol; 2006; 64():167-185. PubMed ID: 16891842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Auditory brainstem implants (ABIs)--20 years of clinical experience in Uppsala, Sweden.
    Siegbahn M; Lundin K; Olsson GB; Stillesjö F; Kinnefors A; Rask-Andersen H; Nyberg G
    Acta Otolaryngol; 2014 Oct; 134(10):1052-61. PubMed ID: 24881643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. English consensus protocol evaluating candidacy for auditory brainstem and cochlear implantation in neurofibromatosis type 2.
    Tysome JR; Axon PR; Donnelly NP; Evans DG; Ferner RE; O'Connor AF; Freeman SR; Gleeson M; Halliday D; Harris F; Jiang D; Kerr R; King A; Knight RD; Lloyd SK; Macfarlane R; Mannion R; Mawman D; O'Driscoll M; Parry A; Ramsden J; Ramsden R; Rutherford SA; Saeed SR; Thomas N; Vanat ZH
    Otol Neurotol; 2013 Dec; 34(9):1743-7. PubMed ID: 24136318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.